Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 20 min ago
Peer-reviewedCC BY-NC-NDOncogenesis

Meeting Report of the 6th edition of metabolism and cancer symposium

  • Ana Carolina B. Sant’Anna-Silva1
  • Chloe Del Bove2
  • Georgios Efthymiou3
  • Emma Henry2
  • Laura Henry2
  • Jigna Kundnani2
  • Rodrigue Rossignol4
  • Sophie Zimmermann2
4 affiliations
  1. 1Nice, France
  2. 2Montpellier, France
  3. 3Marseille, France
  4. 4Bordeaux, France
Read full textPDFDOICite

Abstract

The 6th International Meeting “Metabolism and Cancer” was held at the Convention Center in La Grande Motte, France, on October 8–10, 2025. The three-day conference brought together 240 participants from eleven countries and featured 29 scientific presentations, including 15 invited lectures delivered by leading investigators in the field of oncometabolism. The program was structured into four thematic sessions: (i) diet, cachexia, microbiome, and microenvironment; (ii) stem cells and metabolic plasticity; (iii) epigenetics, epitranscriptomics, and metabolism; and (iv) metabolic control of drug resistance, therapy, and biomarkers. This meeting report highlights key conceptual advances and emerging directions discussed during the conference. Future progress in cancer metabolism will depend on elucidating the cross-talk between tumors and peripheral tissues, as organism-level metabolic regulation is likely to critically influence tumor growth, plasticity, and treatment sensitivity. Moving forward, a systems-level integration of metabolic, genomic, and spatial data is poised to redefine cancer metabolism from a descriptive field into a source of actionable vulnerabilities for precision oncology.

Related

  1. Meeting report of the fifth symposium organized by the coalition to strengthen the HPV immunization community (CHIC): Nairobi, Kenya – advancing sustainable HPV vaccination programs in Africa
    Ana Bolio, Mary Carol Jennings, Ricardo Burdier +17
    BMC ProceedingsPeer-reviewedCC BY 4.0Full textEpidemiology & public healthPMCEurope PMC
  2. Special Issue “Molecular Mechanisms and Therapies of Pancreatic Cancer: 2nd Edition”
    Claudia Vilardo, Annalisa Di Domenico, Donatella Delle Cave
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0OncologyCrossref
  3. Meeting a Proposed Estimated Glomerular Filtration Rate Slope-Based Criterion for Clinical Remission of Chronic Kidney Disease During Sequential Kidney-Protective Therapy in Type 2 Diabetes Mellitus: A Case Report
    Tingting Luo, Liwei Wang, Shichun Huang +1
    Journal of Clinical MedicinePeer-reviewedCC BY 4.0General medicineCrossref
  4. Emerging antibody–drug conjugates in lung cancer: highlights from the 2026 ASCO Annual Meeting
    Xiaolei Wang, Jiayuan Miao, Yuxuan Bao +4
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  5. Chinese Anti-Cancer Association guidelines for holistic integrative management of cancer: prostate cancer (2026 edition)
    Chinese Anti-Cancer Association Genital Oncology Committee
    Zhongguo aizheng zazhiPeer-reviewedCC BY-NC-NDFull textOncologyDOAJ

Cite

BibTeXRIS
BibTeX
@article{santannasilva2026meeting,
  title = {{Meeting Report of the 6th edition of metabolism and cancer symposium}},
  author = {Ana Carolina B. Sant’Anna-Silva and Chloe Del Bove and Georgios Efthymiou and Emma Henry and Laura Henry and Jigna Kundnani and Rodrigue Rossignol and Sophie Zimmermann},
  journal = {Oncogenesis},
  year = {2026},
  month = oct,
  doi = {10.1038/s41389-026-00658-6},
  url = {https://europepmc.org/article/PMC/PMC13691117},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Meeting Report of the 6th edition of metabolism and cancer symposium
AU  - Ana Carolina B. Sant’Anna-Silva
AU  - Chloe Del Bove
AU  - Georgios Efthymiou
AU  - Emma Henry
AU  - Laura Henry
AU  - Jigna Kundnani
AU  - Rodrigue Rossignol
AU  - Sophie Zimmermann
PY  - 2026
DA  - 2026/10/22
JO  - Oncogenesis
DO  - 10.1038/s41389-026-00658-6
UR  - https://europepmc.org/article/PMC/PMC13691117
AB  - The 6th International Meeting “Metabolism and Cancer” was held at the Convention Center in La Grande Motte, France, on October 8–10, 2025. The three-day conference brought together 240 participants from eleven countries and featured 29 scientific presentations, including 15 invited lectures delivered by leading investigators in the field of oncometabolism. The program was structured into four thematic sessions: (i) diet, cachexia, microbiome, and microenvironment; (ii) stem cells and metabolic plasticity; (iii) epigenetics, epitranscriptomics, and metabolism; and (iv) metabolic control of drug resistance, therapy, and biomarkers. This meeting report highlights key conceptual advances and emerging directions discussed during the conference. Future progress in cancer metabolism will depend on elucidating the cross-talk between tumors and peripheral tissues, as organism-level metabolic regulation is likely to critically influence tumor growth, plasticity, and treatment sensitivity. Moving forward, a systems-level integration of metabolic, genomic, and spatial data is poised to redefine cancer metabolism from a descriptive field into a source of actionable vulnerabilities for precision oncology.
SN  - 2157-9024
ER  -